Immunomedics (IMMU) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: jluker who wrote (146)	6/20/1997 8:00:00 PM
From: jluker	of 371

Josh, could you explain what this might mean? thanks jl * IMMUNOMEDICS announced that it has hired its first sales representatives for Germany, Austria and Switzerland to sell LeukoScan, which is approved in the European Union for diagnosing osteomyelitis. The Company said that an application to seek approval for sale of LeukoScan in Switzerland is under preparation. (PR Newswire 02:04 PM ET 06/20/97) For the full text story, see merc.com * IMMUNOMEDICS INC. said that its European filing for a second indicated use for LeukoScan, diagnosing acute, non-classic appendicitis, is not yet approvable, because of the need for certain clarifications by the company. The application for this additional use was filed four months ago. An application to seek approval for sale of LeukoScan in Switzerland is under preparation. (Reuters 04:29 PM ET 06/20/97) For the full text story, see merc.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next